STERICYCLE, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 46.31 USD | -0.43% |
|
-7.21% | -6.56% |
| Apr. 26 | Truist Securities Cuts Stericycle's Price Target to $50 From $57, Hold Rating Maintained | MT |
| Apr. 25 | Transcript : Stericycle, Inc., Q1 2024 Earnings Call, Apr 25, 2024 |
Valuation
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Capitalization 1 | 5,815 | 6,347 | 5,479 | 4,599 | 4,585 | 4,297 | - | - |
| Enterprise Value (EV) 1 | 8,444 | 8,074 | 7,034 | 6,052 | 5,849 | 5,345 | 5,440 | 5,459 |
| P/E ratio | -16.7 x | -110 x | -199 x | 81.8 x | -215 x | 34.6 x | 23.6 x | 13.3 x |
| Yield | - | - | - | - | - | - | - | - |
| Capitalization / Revenue | 1.76 x | 2.37 x | 2.07 x | 1.7 x | 1.72 x | 1.58 x | 1.52 x | 1.44 x |
| EV / Revenue | 2.55 x | 3.02 x | 2.66 x | 2.24 x | 2.2 x | 1.96 x | 1.93 x | 1.83 x |
| EV / EBITDA | 14.6 x | 16.3 x | 15.4 x | 14 x | 13.9 x | 11.2 x | 10 x | 8.54 x |
| EV / FCF | 157 x | 19.7 x | 37.8 x | 89 x | 52.2 x | 24.7 x | 18.9 x | 15.3 x |
| FCF Yield | 0.64% | 5.09% | 2.65% | 1.12% | 1.92% | 4.04% | 5.3% | 6.52% |
| Price to Book | 2.5 x | 2.61 x | 2.29 x | - | - | - | - | - |
| Nbr of stocks (in thousands) | 91,128 | 91,552 | 91,863 | 92,184 | 92,523 | 92,785 | - | - |
| Reference price 2 | 63.81 | 69.33 | 59.64 | 49.89 | 49.56 | 46.31 | 46.31 | 46.31 |
| Announcement Date | 2/27/20 | 2/25/21 | 2/24/22 | 2/23/23 | 2/28/24 | - | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 3,309 | 2,676 | 2,647 | 2,705 | 2,659 | 2,722 | 2,822 | 2,986 |
| EBITDA 1 | 577.8 | 495.2 | 457.8 | 432.2 | 420 | 477.5 | 541.9 | 639.5 |
| EBIT 1 | 452 | 388.6 | 352.4 | 323.7 | 315.5 | 375.2 | 436.6 | - |
| Operating Margin | 13.66% | 14.52% | 13.31% | 11.97% | 11.86% | 13.78% | 15.47% | - |
| Earnings before Tax (EBT) 1 | -362.8 | -56 | 0.7 | 78.9 | 3.3 | 171.4 | 255.4 | - |
| Net income 1 | -346.8 | -57.3 | -27.8 | 56 | -21.4 | 124.3 | 182.2 | 311 |
| Net margin | -10.48% | -2.14% | -1.05% | 2.07% | -0.8% | 4.57% | 6.45% | 10.41% |
| EPS 2 | -3.810 | -0.6300 | -0.3000 | 0.6100 | -0.2300 | 1.340 | 1.965 | 3.470 |
| Free Cash Flow 1 | 53.8 | 410.7 | 186.2 | 68 | 112 | 216.1 | 288.2 | 356 |
| FCF margin | 1.63% | 15.35% | 7.03% | 2.51% | 4.21% | 7.94% | 10.21% | 11.92% |
| FCF Conversion (EBITDA) | 9.31% | 82.94% | 40.67% | 15.73% | 26.67% | 45.26% | 53.18% | 55.67% |
| FCF Conversion (Net income) | - | - | - | 121.43% | - | 173.85% | 158.2% | 114.47% |
| Dividend per Share | - | - | - | - | - | - | - | - |
| Announcement Date | 2/27/20 | 2/25/21 | 2/24/22 | 2/23/23 | 2/28/24 | - | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 657.3 | 664.2 | 679.8 | 690.3 | 670.4 | 684.3 | 669.5 | 653.5 | 652 | 664.9 | 677.3 | 680.5 | 684.4 |
| EBITDA 1 | 92.3 | 86.3 | 109 | 119.3 | 117.6 | 111.3 | 102 | 96.4 | 110.3 | 116.2 | 117.8 | 120.8 | 125 |
| EBIT 1 | 64.2 | 59 | 82 | 92 | 90.6 | 84.7 | 76 | 70.3 | 84.5 | 90.5 | 92.84 | 94.41 | 96.12 |
| Operating Margin | 9.77% | 8.88% | 12.06% | 13.33% | 13.51% | 12.38% | 11.35% | 10.76% | 12.96% | 13.61% | 13.71% | 13.87% | 14.04% |
| Earnings before Tax (EBT) 1 | -8.8 | -11.2 | 18.9 | 33.1 | 38.1 | 19.8 | -43.7 | 6.9 | 20.3 | 20.5 | 48.7 | 50.6 | 51.6 |
| Net income 1 | -17.2 | -14.2 | 10.5 | 28 | 31.8 | 11.2 | -49.5 | 2 | 14.9 | 13.1 | 35.9 | 37.3 | 38 |
| Net margin | -2.62% | -2.14% | 1.54% | 4.06% | 4.74% | 1.64% | -7.39% | 0.31% | 2.29% | 1.97% | 5.3% | 5.48% | 5.55% |
| EPS 2 | -0.1900 | -0.1500 | 0.1100 | 0.3000 | 0.3500 | 0.1200 | -0.5400 | 0.0200 | 0.1600 | 0.1400 | 0.3900 | 0.4000 | 0.4100 |
| Dividend per Share | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Announcement Date | 2/24/22 | 4/28/22 | 8/5/22 | 11/3/22 | 2/23/23 | 4/27/23 | 7/27/23 | 11/2/23 | 2/28/24 | 4/25/24 | - | - | - |
1USD in Million2USD
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net Debt 1 | 2,630 | 1,727 | 1,556 | 1,453 | 1,263 | 1,048 | 1,143 | 1,162 |
| Net Cash position 1 | - | - | - | - | - | - | - | - |
| Leverage (Debt/EBITDA) | 4.551 x | 3.487 x | 3.398 x | 3.362 x | 3.007 x | 2.195 x | 2.109 x | 1.817 x |
| Free Cash Flow 1 | 53.8 | 411 | 186 | 68 | 112 | 216 | 288 | 356 |
| ROE (net income / shareholders' equity) | 9.8% | 8.65% | 8.35% | 7.82% | -0.87% | 6.3% | 7.3% | 10.9% |
| ROA (Net income/ Total Assets) | -5.38% | -0.95% | -0.5% | 1.04% | -0.4% | 2.3% | 3.6% | 5.7% |
| Assets 1 | 6,446 | 6,013 | 5,527 | 5,404 | 5,343 | 5,404 | 5,060 | 5,456 |
| Book Value Per Share | 25.60 | 26.50 | 26.10 | - | - | - | - | - |
| Cash Flow per Share 2 | 3.280 | 5.790 | 2.880 | 3.600 | - | 3.430 | 3.860 | 5.600 |
| Capex 1 | 194 | 120 | 117 | 132 | 131 | 150 | 150 | 150 |
| Capex / Sales | 5.87% | 4.47% | 4.42% | 4.89% | 4.94% | 5.5% | 5.31% | 5.02% |
| Announcement Date | 2/27/20 | 2/25/21 | 2/24/22 | 2/23/23 | 2/28/24 | - | - | - |
1USD in Million2USD
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
B
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
8
Last Close Price
46.31
USD
Average target price
64.6
USD
Spread / Average Target
+39.49%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -6.56% | 4.3B | |
| +9.52% | 42.18B | |
| -4.13% | 12.05B | |
| +5.38% | 5.23B | |
| -1.12% | 3.87B | |
| -1.76% | 2.41B | |
| +6.17% | 2.07B | |
| -7.29% | 1.51B | |
| +2.34% | 1.42B | |
| -12.35% | 1.3B |
- Stock Market
- Equities
- SRCL Stock
- Financials Stericycle, Inc.
